Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jan 17, 2026
Date Accepted: Aug 7, 2026
Diagnostic Accuracy of Artificial Intelligence in Prediction and Assessment of Compromised Free Flaps: A Systematic Review and Meta-Analysis
ABSTRACT
Background:
Vascular compromise remains the leading cause of free-flap failure after microsurgical reconstruction. Artificial intelligence (AI)–based monitoring and prediction tools are emerging adjuncts for assessing viability and anticipating complications.
Objective:
This systematic review and meta-analysis quantify their diagnostic accuracy for flap surveillance and evaluates their role in forecasting adverse outcomes.
Methods:
Following PRISMA-DTA, PubMed, Embase and Cochrane were searched to August 2025 for studies developing AI tools for flap status assessment or prediction. Pooled sensitivity, specificity, AUC and diagnostic odds ratio were estimated using a hierarchical random-effects model. Risk of bias and applicability were assessed with QUADAS-2. Prespecified subgroup analyses by modality, model-fit diagnostics, sensitivity analyses, and publication-bias testing with Deeks’ funnel plot were undertaken.
Results:
Of 512 studies screened, 12 met the inclusion criteria. Pooled analysis demonstrated an overall sensitivity of 0.75 (95% CI: 0.58–0.87), specificity of 0.88 (95% CI: 0.77–0.94), AUC of 0.89 (95% CI: 0.86–0.92), and DOR 22 (95% CI: 6-85). Image-based AI models demonstrated notably higher diagnostic accuracy, with a sensitivity of 0.93 (95% CI: 0.82–0.98), specificity of 0.93 (95% CI: 0.82–0.98), and AUC of 0.98 (95% CI: 0.96-0.99). In contrast, clinical-variable model yielded more modestly overall. For vascular compromise prediction, pooled sensitivity was 0.90 (95% CI: 0.79–0.95) and specificity 0.90 (95% CI: 0.78–0.95). Between-study heterogeneity was moderate, and QUADAS-2 indicated an overall moderate risk of bias.
Conclusions:
AI is a promising adjunct for flap surveillance and complication prediction, but its clinical utility and safe integration require confirmation in large, prospective, multicenter studies. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.